Orin Hirschman 13D and 13G filings for TransCode Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-10-27 08:08 am Sale | 2022-10-26 | 13G | TransCode Therapeutics, Inc. RNAZ | Orin Hirschman | 0 0.000% | -49 (Position Closed) | Filing |
| 2022-02-11 3:06 pm Purchase | 2021-12-31 | 13G | TransCode Therapeutics, Inc. RNAZ | Orin Hirschman | 49 9.900% | 1 (+1.46%) | Filing |
| 2021-07-20 5:55 pm Purchase | 2021-07-09 | 13G | TransCode Therapeutics, Inc. RNAZ | Orin Hirschman | 48 9.900% | 48 (New Position) | Filing |